enzalutamide
pfizer,astellas
['enzamet', 'triplet']
some hints re which patients should receive triplet therapy in mhspc from enzamet but trial can t definitely answer the question as docetaxel use not randomised so outcomes also influenced by prognostic factors in this group #asco2022 
An Australian oncologist with an interest in GU malignancies, phase 1 trials, cycling and having fun with the family